Author

Marco Gobbi

Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Cited by 10,529 - biochemistry - pharmacology - neuroscience

Biography

Dr. Marco Gobbi currently serves as a Head of the Laboratory of Pharmacodynamics and Pharmacokinetics at the "Mario Negri" Institute for Pharmacological Research, Italy. He has published many research articles on his research interests in various national and international journals.
Title
Cited by
Year
A portable optical-fibre-based surface plasmon resonance biosensor for the detection of therapeutic antibodies in human serum
L Zeni, C Perri, N Cennamo, F Arcadio, G D’Agostino, M Salmona, ...Scientific reports 10 (1), 11154, 2020202
76
2020
Plasma and brain concentrations of doxycycline after single and repeated doses in wild-type and APP23 mice
J Lucchetti, C Fracasso, C Balducci, A Passoni, G Forloni, M Salmona, ...Journal of Pharmacology and Experimental Therapeutics 368 (1), 32-40, 2019201
49
2019
A surface plasmon resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
M Beeg, A Nobili, B Orsini, F Rogai, D Gilardi, G Fiorino, S Danese, ...Scientific reports 9 (1), 2064, 2019201
49
2019
Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects
P La Vitola, M Beeg, C Balducci, G Santamaria, E Restelli, L Colombo, ...Brain 142 (2), 249-254, 2019201
43
2019
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
D Buonfrate, F Chesini, D Martini, MC Roncaglioni, MLO Fernandez, ...International journal of antimicrobial agents 59 (2), 106516, 2022202
40
2022
Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury
D De Blasio, S Fumagalli, L Longhi, F Orsini, A Palmioli, M Stravalaci, ...Journal of Cerebral Blood Flow & Metabolism 37 (3), 9-950, 2017201
38
2017
The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines
P Bigini, M Gobbi, M Bonati, A Clavenna, M Zucchetti, S Garattini, G PasutNature nanotechnology 16 (11), 1169-1171, 2021202
38
2021
QSAR model for blood-brain barrier permeation
AA Toropov, AP Toropova, M Beeg, M Gobbi, M SalmonaJournal of pharmacological and toxicological methods 88, 7-18, 2017201
33
2017
Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS
A Piotti, D Novelli, JMTA Meessen, D Ferlicca, S Coppolecchia, A Marino, ...Critical Care 25 (1), 1-12, 2021202
30
2021
The anti-amyloidogenic action of doxycycline: a molecular dynamics study on the interaction with Aβ42
A Gautieri, M Beeg, M Gobbi, F Rigoldi, L Colombo, M SalmonaInternational journal of molecular sciences 20 (18), 4641, 2019201
28
2019
Fingolimod limits acute Aβ neurotoxicity and promotes synaptic versus extrasynaptic NMDA receptor functionality in hippocampal neurons
P Joshi, M Gabrielli, L Ponzoni, S Pelucchi, M Stravalaci, M Beeg, ...Scientific reports 7 (1), 41734, 2017201
27
2017
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein
C Stincardini, T Massignan, S Biggi, SR Elezgarai, V Sangiovanni, I Vanni, ...PloS one 12 (8), e0182589, 2017201
23
2017
The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions
E Varone, A Decio, A Chernorudskiy, L Minoli, L Brunelli, F Ioli, A Piotti, ...Oncogene 40 (9), 1721-1736, 2021202
22
2021
Can antiviral activity of licorice help fight COVID-19 infection?
L Diomede, M Beeg, A Gamba, O Fumagalli, M Gobbi, M SalmonaBiomolecules 11 (6), 855, 212
20
2021
Ventilation with argon improves survival with good neurological recovery after prolonged untreated cardiac arrest in pigs
F Fumagalli, D Olivari, A Boccardo, D De Giorgio, R Affatato, S Ceriani, ...Journal of the American Heart Association 9 (24), e016494, 2020202
19
2020
Utilization of the Monte Carlo method to build up QSAR models for hemolysis and cytotoxicity of antimicrobial peptides
AP Toropova, AA Toropov, M Beeg, M Gobbi, M SalmonaCurrent Drug Discovery Technologies 14 (4), 229-243, 2017201
18
2017
Characterization of the neutralizing anti‐emicizumab antibody in a patient with hemophilia A and inhibitor
C Valsecchi, M Gobbi, M Beeg, T Adams, G Castaman, L Schiavone, ...Journal of Thrombosis and Haemostasis 19 (3), 711-718, 2021202
17
2021
Efficacy of cholesterol nose-to-brain delivery for brain targeting in Huntington’s disease
A Passoni, M Favagrossa, L Colombo, R Bagnati, M Gobbi, L Diomede, ...ACS Chemical Neuroscience 11 (3), 367-372, 2019201
15
2019
A new surface plasmon resonance assay for in vitro screening of mannose-binding lectin inhibitors
M Stravalaci, D De Blasio, F Orsini, C Perego, A Palmioli, G Goti, ...Journal of Biomolecular Screening 21 (7), 749-757, 2016201
11
2016
Ascites interferes with the activity of lurbinectedin and trabectedin: potential role of their binding to alpha 1-acid glycoprotein
E Erba, M Romano, M Gobbi, M Zucchetti, M Ferrari, C Matteo, N Panini, ...Biochemical pharmacology 144, 52-62, 2017201
10
2017

Referred From: https://scholar.google.com/citations?hl=th&user=j89eOGQAAAAJ

Cited by
Citations 10529
h-index 50
i10-index 152
Open Access Journals